Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF) (2016 - 2021)
Rhythm Pharmaceuticals (RYTM) reported Depreciation & Amortization (CF) of $315000.0 for Q3 2021, up 83.14% year-over-year from $172000.0 in Q3 2020, and down 0.63% quarter-over-quarter from $317000.0 in Q2 2021.
Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF) (2016 - 2021) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $315000.0 in Q3 2021.
- Depreciation & Amortization (CF) for Q3 2021 came in at $315000.0, up 83.14% year-over-year; the trailing twelve-month figure through Jun 2022 was $315000.0 (down 63.71% YoY), and the FY2020 annual result was $690000.0, down 17.27% from the prior year.
- Depreciation & Amortization (CF) eased to $315000.0 in Q3 2021 per RYTM's latest filing, from $317000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $317000.0 in Q2 2021 and troughed at $54000.0 in Q1 2017.
- A 5-year average of $159052.6 and a median of $173000.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2019 and 2020: Depreciation & Amortization (CF) soared 301.64% in 2019, then plunged 31.84% in 2020.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $60000.0 in 2017, then surged by 256.67% to $214000.0 in 2018, then slipped by 10.75% to $191000.0 in 2019, then fell by 6.81% to $178000.0 in 2020, then surged by 76.97% to $315000.0 in 2021.
- Business Quant data shows RYTM's Depreciation & Amortization (CF) at $315000.0 in Q3 2021, $317000.0 in Q2 2021, and $201000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 315,000.00 |
| Sep 30, 2021 | 315,000.00 |
| Jun 30, 2021 | 317,000.00 |
| Jun 30, 2021 | 317,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Dec 31, 2020 | 178,000.00 |
| Dec 31, 2020 | 178,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Jun 30, 2020 | 173,000.00 |
| Jun 30, 2020 | 173,000.00 |
| Mar 31, 2020 | 167,000.00 |
| Mar 31, 2020 | 167,000.00 |
| Dec 31, 2019 | 191,000.00 |
| Dec 31, 2019 | 191,000.00 |
| Sep 30, 2019 | 191,000.00 |
| Sep 30, 2019 | 191,000.00 |
| Jun 30, 2019 | 207,000.00 |
| Jun 30, 2019 | 207,000.00 |